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Introduction
Lichen sclerosus (LS) is a chronic, inflammatory, mucocutane-
ous disorder of the genital and extragenital skin. Itching is the 
main complaint in genital LS in women, and sexual and urinary 
dysfunction in men (1). Anogenital warts are benign proliferative 
lesions caused by human papillomavirus (HPV) types 6 and 11, 
found in > 95% of lesions (2, 3). HPV infection is the most prevalent 
sexually transmitted genital infection. The lifetime risk of infec-
tion is around 75% (4), and it is correlated with sexual behavior (5).
The etiology of genital LS is unknown. Many factors are im-
plicated as possible causative agents: hormonal factors, autoim-
munity, HLA-DQ7 association, specific local immune reaction, 
trauma (Koebner phenomenon), and infections (1, 6). There are 
no clear data showing that infections—namely, those caused by 
Borrelia burgdorferi, Epstein–Barr virus, HPV, and hepatitis C—
are causative agents for genital LS (1, 6).
Case reports
Case 1
A 32-year-old healthy man presented with tightening of the fore-
skin, itching, narrowing of the urinary stream, bleeding during 
urination, dyspareunia, and occasional tearing of the prepuce 
and frenulum during sexual intercourse. Two years before the 
visit he was treated for genital warts with cryotherapy. On clini-
cal examination, a pearly white, smooth area of the glans of the 
penis and coronal sulcus together with intraurethral papilloma-
tous lesions at the external urethral meatus were observed (Fig. 
1). Biopsy showed histological signs suggestive of condyloma 
acuminatum without dysplasia. HPV detection using polymerase 
chain reaction (PCR) of the verrucous lesion was positive for both 
high-risk (types 16, 18, 31, 35) and low-risk (types 6, 11, 34) HPV 
types, whereas HPV detection of the sclerotic lesion was positive 
for low-risk types (types 6, 11) and negative for high-risk types. 
Urethral swabs for sexually transmitted infections (STIs) and se-
rology for syphilis, HIV, and hepatitis were negative. Initially the 
patient was treated twice with electrocautery for intraurethral 
warts. After the condyloma cleared, clobetasol propionate 0.05% 
ointment was applied once a day for 3 months. The frequency of 
local corticosteroid application was then reduced to every other 
day for 1 month, twice a week for another month, and finally once 
a week for a month. The patient was advised to stop corticosteroid 
treatment if the genital warts reappeared. Intraurethral condylo-
mas reoccurred 6 months and then again 8 months after LS had 
cleared, and they were again treated with electrocautery. The pa-
tient has remained in follow-up for 2 years.
Case 2
A 56-year-old man with no history of genital warts and no history 
of other STIs  presented to us with an 8-month history of penile er-
ythema, tightening of the foreskin, ecchymoses, meatal stenosis, 
and dyspareunia (Fig. 2). He claimed that he had been in a mo-
nogamous relationship with his wife for over 30 years. Biopsy was 
consistent with LS, and he was prescribed treatment with clobet-
asol propionate 0.05% ointment two times a day for a month, then 
once a day until the follow-up visit scheduled for 3 months after the 
initial visit. Eight weeks after the LS therapy had been initiated, a 
verrucous lesion appeared on the glans of the penis (Fig. 3). A bi-
opsy of the lesion showed condyloma acuminatum, and PCR was
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Figure 1 | Lichen sclerosus of the penis and coronal sulcus together with intrau-
rethral papillomatous lesions at the external urethral meatus.
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positive for HPV types 6 and 11. HPV detection of the sclerotic 
lesion was negative for both high-risk and low-risk HPV types. 
Tests for other STIs were negative. Electrocautery was performed 
three times and cryotherapy two times. After each condyloma had 
cleared, clobetasol propionate 0.05% ointment was applied once 
a day for 3 months, and then the frequency of application was 
gradually reduced. The patient was advised to stop corticosteroid 
treatment if genital warts reappeared. Because of frequent genital 
wart recurrence, imiquimod 5% cream for 14 weeks together with 
clobetasol propionate 0.05% ointment were applied. The duration 
of the treatment was 1 year. Neither visible warts nor LS lesions 
were observed at 2 years’ follow-up. 
Discussion
HPV infection has been implicated as a causative agent of geni-
tal LS (1, 6). The median prevalence of HPV in genital LS is 22% 
(6). One could expect a much higher prevalence of HPV in genital 
LS because the lifetime prevalence of HPV is high (4). There are 
some facts that contradict the association of genital LS and HPV 
as a causative agent, such as the fact that genital LS is never seen 
in sexual partners; moreover, despite widespread immunization 
against HPV, there is no decline in the genital LS incidence, and 
so it can be concluded that there is a lack of clinical correlation of 
LS with HPV infection (6–8). Von Krogh et al. found that 32% of 
men afflicted with LS revealed a positive history of penile warts 
(7). HPV reactivation seemed to increase after local corticosteroid 
therapy. Reactivation of a latent HPV infection may be evoked 
following topical corticosteroid therapy because of an altered im-
mune response (6, 7).
Both of our patients claimed to have been monogamous, with-
out any history of genital skin diseases. The first patient had a 
history of condylomata 2 years prior to the LS development, but 
without LS treatment. The second patient did not have a history 
of genital warts, and a verrucous lesion appeared after local corti-
costeroid therapy of LS. The possible trigger factor in the first case 
could have been the previous treatment with cryotherapy, which 
could have caused a trauma (the Koebner phenomenon). In the 
second case, local corticosteroid, due to an altered immune re-
sponse, reactivated a latent HPV infection that had probably been 
acquired many years prior. Imiquimod can be an effective choice 
for the treatment of LS (6) associated with HPV (9), but it can also 
provoke the development of LS (10). In our patient, imiquimod 
therapy in combination with local corticosteroid therapy resulted 
in the regression of both genital warts and an LS lesion. HPV tests 
of atrophic genital lesions are frequently negative. That could be 
explained by the fact that HPV could trigger an immune response 
giving rise to LS and yet be cleared by the time of biopsy (6), or 
that HPV can reside focally and an HPV test can be negative if the 
biopsy was taken in an area without HPV (6).
Conclusion
Patients with genital LS and HPV infection should be closely 
monitored for HPV-associated lesions following therapy with lo-
cal corticosteroids. We suggest follow-up visits up to 2 years after 
clinical remission.
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Figure 2 | Lichen sclerosus of the penis presenting with a pearly white, smooth 
area, ecchymoses, and meatal stenosis.
Figure 3 | Lichen sclerosus of the penis and a verrucous lesion on the glans of 
the penis.
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